🇺🇸 FDA

Company profile · Sponsor

Shuttle

Shuttle Pharmaceuticals Holdings

SHPH · NYSE pharma GAITHERSBURG, MD, USA
Pipeline
1
Drugs
0
Patents
8

Quick answer

Shuttle (SHPH) is a pharma company. headquartered in GAITHERSBURG, MD, USA. listed on NYSE. NovaPharmaNews links 1 pipeline program, 0 drugs, and 8 patents to this profile..

Company facts

Ticker SHPH
Exchange NYSE
Company type pharma
Headquarters GAITHERSBURG, MD, USA
SEC CIK 0001757499

Pipeline (1)

Search pipeline →

  1. Ropidoxuridine

    Shuttle

    Glioblastoma, IDH-wildtype

    phase 2 small molecule terminated

    1 trial

Patents (8)

Search patents →

  1. US 12357650

    Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorlylase inhibitors in combination with radiation

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12077515

    Selective histone deacetylase inhibitors for the treatment of human disease

    Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11654157

    Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation

    Expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11584733

    Selective histone deacetylase inhibitors for the treatment of human disease

    Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11407723

    Selective histone deacetylase inhibitors for the treatment of human disease

    Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11034667

    Selective histone deacetylase inhibitors for the treatment of human disease

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10745352

    Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof

    Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10730834

    Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Shuttle?

Shuttle (SHPH) is a pharma company. headquartered in GAITHERSBURG, MD, USA. listed on NYSE. NovaPharmaNews links 1 pipeline program, 0 drugs, and 8 patents to this profile..

What pipeline programs does Shuttle sponsor?

We track 1 ClinicalTrials.gov-linked program for Shuttle, including Ropidoxuridine. Open each program for phase, modality, NCT IDs, and indication details.

Where does Shuttle company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.